Inhaled & Nasal Biologics | DNA Forum 2025

Join us for a ground-breaking and insightful forum on inhaled and nasal biologics or inhaled vaccine development: Two days of cutting-edge talks and networking opportunities with leaders in this complex area of drug and vaccine development.

4th Annual Inhaled & Nasal Biologics | DNA Forum
25-26th September 2025 
Cambridge, UK 

 SPEAKERS  |  REGISTRATION   |  VENUE  |  FIVE REASONS TO ATTEND

We are delighted to announce that we are hosting the 4th edition of the Annual Inhaled & Nasal Biologics | DNA Forum in September 2025 with the Academy of Pharmaceutical Sciences (APS) as Conference Partner. We invite you to join two days of cutting-edge talks and networking opportunities with leaders in this complex area of drug product and inhaled vaccines development.

Biologics and nucleotide-based therapeutics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these presents a compelling, non-invasive alternative to traditional parenteral methods, offering potential for both local respiratory and systemic treatments across a variety of diseases and indications. However, biologics, mRNA, nucleotide-based therapeutics and vaccines present unique challenges for respiratory administration and whilst there can be many ways to design a product, the developer needs to balance, amongst many other things, product performance, manufacturability, regulatory risk, and commercial elements. 

During this 4th edition, the conference will provide a platform for discussing the latest research and optimal strategies for pulmonary and intranasal biologic/DNA drug development. With renowned industry leaders who will share their insight and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don't miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics. 

Call for Poster Presentation Submissions
During the conference, the APS will host a scientific poster session. This session is open for researchers and innovators at all levels to share their work in the field of inhaled and nasal biologics or vaccine development. The call for poster submissions is open now. As a delegate, if you would like to bring a poster, please submit here.

Secure your place today - registration is live. 

REGISTRATION

2025 Registration fees per attendee includes the conference registration, accommodation at Hinxton Hall if required, the conference dinner and networking drinks.

MEET OUR SPEAKERS

We will be releasing more news of our esteemed speakers over the coming weeks. Be sure to bookmark this page and follow us on LinkedIn to stay updated with the latest developments. 

WHAT TO EXPECT AT THE EVENT

Considering attending? Here’s what awaits you at the Forum:

✔️ 2 Days of Expert Talks: Dive into cutting-edge discussions and insights delivered by leaders in the complex area of drug product and inhaled vaccine development.

✔️ Budget-Friendly: As a cost-effective event, the registration fee includes conference registration, accommodation at Hinxton Hall if required, the conference dinner, and networking drinks.

✔️ Everything Organized for You: From networking opportunities and a poster session hosted by the APS, to accommodation and drinks gatherings, we’ve got it covered.

✔️ Networking: Connect with industry leaders and expand your professional circle. The event brings together a diverse range of industry stakeholders, including academics, pharma and biotech pioneers, device experts, start-ups, students, and supporting players, providing a unique platform for networking.

✔️ Learning and Insights: Attendees benefit from a wealth of real-life case studies and insights shared by leaders in the field, offering invaluable learnings on how to effectively develop these medicines to achieve better patient outcomes.

VENUE